Opinion | Drug Prices Improved Under Biden-Harris and Trump, But Not for Everyone and Not Enough
When it comes to drug pricing, the Trump and Biden-Harris administrations both have some very modest wins to tout. As director of the Health Outcomes, Policy, and Evidence Synthesis group at the University of Connecticut School of Pharmacy, I teach and …